- 자료제공 :
- Acknowledgements vii 1 Introduction 1
Jeremy A. Greene and Sergio Sismondo Part I Pharmaceutical Lives 17 2 The Pharmaceuticalisation of Society? A Framework for Analysis 19
Simon J. Williams, Paul Martin and Jonathan Gabe 3 Pharmaceutical Witnessing: Drugs for Life in an Era of Directi¿½]toi¿½]Consumer Advertising 33
Joseph Dumit Part II New Drugs, Diseases, and Identities 49 4 Releasing the Flood Waters: Diuril and the Reshaping of Hypertension 51
Jeremy A. Greene 5 DepRession and Consumi¿½i¿½tion: Psychopharmaceuticals, Branding, and New Identity Practices 70
Nathan Greenslit 6 BiDil: Medicating the Intersection of Race and Heart Failure 87
Anne Pollock 7 Manufacturing Desire: The Commodification of Female Sexual Dysfunction 106
Jennifer R. Fishman Part III Drugs and the Circulation of Medical Knowledge 121 8 Following the Script: How Drug Reps Make Friends and Influence Doctors 123
Adriane Fughi¿½]Berman and Shahram Ahari 9 Getting to Yes: Corporate Power and the Creation of a Psychopharmaceutical Blockbuster 133
Kalman Applbaum 10 Pushing Knowledge in the Drug Industry: Ghosti¿½]Managed Science 150
Sergio Sismondo 11 Transcultural Medicine: A Multii¿½]Sited Ethnography on the Scientifici¿½]Industrial Networking of Korean Medicine 165
Jongyoung Kim Part IV Political and Moral Economies of Pharmaceutical Research 179 12 Uncommon Trajectories: Steroid Hormones, Mexican Peasants, and the Search for a Wild Yam 181
Gabriela Soto Laveaga 13 “Readyi¿½]toi¿½]Recruit” or “Readyi¿½]toi¿½]Consent” Populations? Informed Consent and the Limits of Subject Autonomy 195
Jill A. Fisher 14 Clinical Trials Offshored: On Private Sector Science and Public Health 208
Adriana Petryna 15 The Experimental Machinery of Global Clinical Trials: Case Studies from India 222
Kaushik Sunder Rajan Part V Intellectual Property in Local and Global Markets 235 16 Intellectual Property and Public Health: Copying of HIV/AIDS Drugs by Brazilian Public and Private Pharmaceutical Laboratories 237
Maurice Cassier and Marilena Correa 17 Global Pharmaceutical Markets and Corporate Citizenship: The Case of Novartis’ Antii¿½]Cancer Drug Glivec 247
Stefan Ecks 18 Generic Medicines and the Question of the Similar 261
Cori Hayden Index 268